In:
Paediatrics & Child Health, Oxford University Press (OUP), Vol. 25, No. 7 ( 2020-11-02), p. 455-466
Abstract:
Retinopathy of prematurity (ROP) is a potentially blinding condition affecting premature infants for which less than 10% of babies undergoing screening require treatment. This study assessed and validated predictors of developing clinically significant ROP (type 2 or worse) and ROP requiring treatment. Design Nationwide retrospective cohort study. Methods This study included infants born between January 2014 and June 2016, admitted to level 3 neonatal intensive care units across Canada who underwent ROP screening. Data were derived from the Canadian Neonatal Network database. Predefined ≥ 1% risk for clinically significant retinopathy or prematurity and ROP requiring treatment was set as threshold for screening. Thirty-two potential predictors were analyzed, to identify and validate the most important ones for predicting clinically significant ROP. The predictors were determined on a derivation cohort and tested on a validation cohort. Multivariable logistic regression modeling was used for analysis. Results Using a sample of 4,888 babies and analyzing 32 potential predictors, capturing babies with ≥1% risk of developing clinically significant ROP equated to screening babies with birth weight (BW) & lt;1,300 g or gestational age (GA) & lt;30 weeks while capturing babies with ≥1% risk of requiring ROP treatment equated to screening babies with BW & lt;1,200 g or GA & lt;29 weeks. Conclusions The Canadian ROP screening criteria can be modified to screen babies with BW & lt;1,200 g or GA & lt;30 weeks. Using these criteria, babies requiring treatment would be identified while reducing the number of babies screened unnecessarily.
Type of Medium:
Online Resource
ISSN:
1205-7088
,
1918-1485
Language:
English
Publisher:
Oxford University Press (OUP)
Publication Date:
2020
detail.hit.zdb_id:
2174400-2
Permalink
